Cytokine involvement in dynorphin-induced allodynia

Pain

Volumn 84, Issue 2-3, 2000, Pages 159-167

  Laughlin, Tinna M ^a   Bethea, John R ^b   Yezierski, Robert P ^b   Wilcox, George L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Cytokines; IL 10; Interleukin 1beta; Neuropathic pain; NF B; Protein synthesis

Indexed keywords

ANTIINFLAMMATORY AGENT; CASPASE INHIBITOR; CYCLOHEXIMIDE; CYTOKINE; DYNORPHIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; PROTEIN SYNTHESIS INHIBITOR; PYRROLIDINE DITHIOCARBAMATE; TRANSCRIPTION FACTOR;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DRUG ANTAGONISM; MALE; MOUSE; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SPINAL CORD;

ANIMALS; CYTOKINES; DYNORPHINS; HYPERESTHESIA; INTERLEUKIN-1; INTERLEUKIN-10; MALE; MICE; MICE, INBRED ICR; NF-KAPPA B; PROTEIN BIOSYNTHESIS;

EID: 0033968757     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00195-5     Document Type: Article

References (81)

1. Alstergren P., Ernberg M., Kvarnstrom M., Kopp S. Interleukin-1beta in synovial fluid from the arthritic temporomandibular joint and its relation to pain, mobility, and anterior open bite. J Oral Maxillofac Surg. 56:1998;1059-1065.
2. Aronowski J., Strong R., Groffa J.C. Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab. 17:1997;1048-1056.
3. Baeuerle P.A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 12:1994;141-179.
4. Balasingam V., Yong V.W. Attenuation of astroglial reactivity by interleukin-10. J Neurosci. 16:1996;2945-2955.
5. Barnes P.J., Adcock I.M. NF-kappa B: a pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci. 18:1997;46-50.
6. Bethea J.R., Castro M., Keane R.W., Lee T.T., Dietrich W.D., Yezierski R.P. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J Neurosci. 18:1998;3251-3260.
7. Bethea J.R., Nagashima H., Acosta M., Briceno C., Gomez F., Loor K., Green J., Dietrich W.D. Systemically administered interleukin-10 (IL-10) reduces tumor necrosis factor alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrama. 1999;in press.
8. Bhat R.V., DiRocco R., Marcy V.R., Flood D.G., Zhu Y., Dobrzanski P., Siman R., Scott R., Contreras P.C., Miller M. Increased expression of IL-1beta converting enzyme in hippocampus after ischemia: selective localization in microglia. J Neurosci. 16:1996;4146-4154.
9. Brewer K.L., Bethea J.R., Yezierski R.P. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Exp Neurol. 1999;in press.
10. Buttini M., Sauter A., Boddeke H.W. Induction of interleukin-1 beta mRNA after focal cerebral ischaemia in the rat. Brain Res Mol Brain Res. 23:1994;126-134.
11. Caratsch C.G., Santoni A., Eusebi F. Interferon-alpha, beta and tumor necrosis factor-alpha enhance the frequency of miniature end-plate potentials at rat neuromuscular junction. Neurosci. Lett. 166:1994;97-100.
12. Cerreffi D.P., Kozlosky C.J., Mosley B., Nelson N., Van Ness K., Greenstreet T.A., March C.J., Kronheim S.R., Druck T., Cannizzaro L.A., et al. Molecular cloning of the interleukin-1 beta converting enzyme. Science. 256:1992;97-100.
13. Chao C.C., Gekker G., Hu S., Sheng W.S., Portoghese P.S., Peterson P.K. Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin. Biochem Pharmacol. 50:1995;715-722.
14. Chao C.C., Hu S., Ehrlich L., Peterson P.K. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun. 9:1995;355-365.
15. Chen Y.H., Lin Q., Willis W.D. Nf-Kappa B transcription factor expression in rat spinal cord following intradermal injection of capsaicin. American Pain Society Meeting, Abstract. 1998;104.
16. Clemens J.A., Stephenson D.T., Smaistig B.B., Dixon B.P., Little S.P. Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats. Stroke. 28:1997;1073-1080.
17. Cooper M., Lindholm P., Pieper G., Seibel R., Moore G., Nakanishi A., Dembny K., Komorowski R., Johnson C. Myocardial nuclear factor-kappaB activity and nitric oxide production in rejecting cardiac allografts. Transplantation. 66:1998;838-844.
18. Cox B.M., Molineaux C.J., Jacobs T.P., Rosenberger J.G., Faden A.I. Effects of traumatic injury on dynorphin immunoreactivity in spinal cord. Neuropeptides. 5:1985;571-574.
19. Davis A.J., Perkins M.N. Substance P and capsaicin-induced mechanical hyperalgesia in the rat knee joint; the involvement of bradykinin B1 and B2 receptors. Br J Pharmacol. 118:1996;2206-2212.
20. DeLeo J.A., Colburn R.W., Nichols M., Malhotra A. Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J. Interferon Cytokine Res. 16:1996;695-700.
21. DeLeo J.A., Colburn R.W., Rickman A.J. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res. 759:1997;50-57.
22. Dinarello C.A. Biology of interleukin 1. FASEB J. 2:1988;108-115.
23. Dubner R., Ruda M.A. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 15:1992;96-103.
24. Ehrlich L.C., Hu S., Peterson P.K., Chao C.C. IL-10 down-regulates human microglial IL-8 by inhibition of NF-kappaB activation. NeuroReport. 9:1998;1723-1726.
25. Ferreira S.H., Lorenzetti B.B., Bristow A.F., Poole S. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature. 334:1988;698-700.
26. Fiorentino D.F., Ziotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 147:1991;3815-3822.
27. Giulian D., Lachman L.B. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science. 228:1985;497-499.
28. Goto K., Ishige A., Sekiguchi K., Iizuka S., Sugimoto A., Yuzurihara M., Aburada M., Hosoya B., Kogure K. Effects of cycloheximide on delayed neuronal death in rat hippocampus. Brain Res. 534:1990;299-302.
29. Griffin W.S., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L.d., Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA. 86:1989;7611-7615.
30. Grilli M., Goffi F., Memo M., Spano P. Interleukin-l-beta and glutamate activate the NF-kappa-B/rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J Biol Chem. 271:1996;15002-15007.
31. Grilli M., Pizzi M., Memo M., Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappa-B activation. Science. 274:1996;1383-1385.
32. Guerrini L., Blasi F., Denis-Donini S. Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro. Proc Natl Acad Sci USA. 92:1995;9077-9081.
33. Heese K., Fiebich B.L., Bauer J., Otten U. NF-kappaB modulates lipopolysaccharide-induced microglial nerve growth factor expression. Glia. 22:1998;401-407.
34. Hofman F.M., von Hanwehr R.I., Dinarello C.A., Mizel S.B., Hinton D., Merrill J.B. Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain. J Immunol. 136:1986;3239-3245.
35. Hylden J.L.K., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur J Pharmacol. 67:1980;313-316.
36. Iadarola M.J., Brady L.S., Draisci G., Dubner R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding. Pain. 35:1988;313-326.
37. Issazadeh S., Ljungdahl A., Hojeberg B., Mustafa M., Olsson T. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor alpha and tumor necrosis factor beta. J Neuroimmunol. 61:1995;205-212.
38. Iuvone T., D'Acquisto F., Van Osselaer N., Di Rosa M., Carnuccio R., Herman A.G. Evidence that inducible nitric oxide synthase is involved in LPS-induced plasma leakage in rat skin through the activation of nuclear factor-kappa B. Br J Pharmacol. 123:1998;1325-1330.
39. Jeanjean A.P., Moussaoui S.M., Maloteaux J.M., Laduron P.M. Interleukin-1 beta induces long-term increase of axonally transported opiate receptors and substance P. Neuroscience. 68:1995;151-157.
40. Jones L.S., Grooms S.Y., Lapadula D.M., Lewis D.V. Protein synthesis inhibition blocks maintenance but not induction of epileptogenesis in hippocampal slice. Brain Res. 599:1992;338-344.
41. Kajander K.C., Sahara Y., ladarola M.J., Bennett G.J. Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy. Peptides. 11:1990;719-728.
42. Kaltschmidt C., Kaltschmidt B., Baeuerle P.A. Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. Proc Natl Acad Sci USA. 92:1995;9618-9622.
43. Kaltschmidt C., Kaltschmidt B., Lannes-Vieira J., Kreutzberg G.W., Wekerle H., Baeuerle P.A., Gehrmann J. Transcription factor NF-kappa B is activated in microglia during experimental autoimmune encephalomyelitis. J Neuroimmunol. 55:1994;99-106.
44. Kharlamov A., Joo J.Y., Uz T., Manev H. Cycloheximide reduces the size of lesion caused in rats by a photothrombotic model of brain injury. Neurol Res. 19:1997;92-96.
45. Kong J.Q., Leedham J.A., Taylor D.A., Fleming W.W. Evidence that tolerance and dependence of guinea pig myenteric neurons to opioids is a function of altered electrogenic sodium-potassium pumping. J Pharmacol Exp Ther. 280:1997;593-599.
46. Laughlin T.M., Vanderah T., Lashbrook J.M., Nichols M.L., Ossipov M.H., Porecca F., Wilcox G.L. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain. 72:1997;253-260.
47. Lentsch A.B., Shanley T.P., Sarma V., Ward P.A. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. J Clin Invest. 100:1997;2443-2448.
48. Lindholm D., Heumann R., Meyer M., Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature. 330:1987;658-659.
49. Liu X.Z., Xu X.M., Hu R., Du C., Zhang S.X., McDonald J.W., Dong H.X., Wu Y.J., Fan G.S., Jacquin M.F., Hsu C.Y., Choi D.W. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci. 17:1997;5395-5406.
50. Loddick S.A., Rothwell N.J. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab. 16:1996;932-940.
51. Malcangio M., Bowery N.G., Flower R.J., Perretti M. Effect of interleukin-1 beta on the release of substance P from rat isolated spinal cord. Eur J Pharmacol. 299:1996;113-118.
52. Merrill J.B., Chen I.S. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J. 5:1991;2391-2397.
53. Oka T., Aou S., Hori T. Intracerebroventricular injection of interleukin-1 beta induces hyperalgesia in rats. Brain Res. 624:1993;61-68.
54. Oka T., Aou S., Hon T. Intracerebroventricular injection of interleukin-1 beta enhances nociceptive neuronal responses of the trigeminal nucleus caudalis in rats. Brain Res. 656:1994;236-244.
55. O'Neill L.A., Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20:1997;252-258.
56. Patterson P.H., Nawa H. Neuronal differentiation factors/cytokines and synaptic plasticity. Cell. 72:1993;123-137.
57. Pavlik A., Teisinger J. Effect of cycloheximide administered to rats in early postnatal life: prolonged inhibition of DNA synthesis in the developing brain. Brain Res. 192:1980;53-541.
58. Perez-Otano I., McMillian M.K., Chen J., Bing G., Hong J.S., Pennypacker K.R. Induction of NF-kB-like transcription factors in brain areas susceptible to kainate toxicity. Glia. 16:1996;306-315.
59. Poole S., Cunha F.Q., Selkirk S., Lorenzetti B.B., Ferreira S.H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. Br J Pharmacol. 115:1995;684-688.
60. Rong Y., Baudry M. Seizure activity results in a rapid induction of nuclear factor-kappa B in adult but not juvenile rat limbic structures. J Neurochem. 67:1996;662-668.
61. Rongione A.J., Kusske A.M., Ashley S.W., Reber H.A., McFadden D.W. Interleukin-10 prevents early cytokine release in severe intraabdominal infection and sepsis. J Surg Res. 70:1997;107-112.
62. Safieh-Garabedian B., Poole S., Allchorne A., Winter J., Woolf C.J. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol. 115:1995;1265-1275.
63. Schreck R., Meier B., Mannel D.N., Droge W., Baeuerle P.A. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med. 175:1992;1181-1194.
64. Shadiack A.M., Hart R.P., Carlson C.D., Jonakait G.M. Interleukin-1 induces substance P in sympathetic ganglia through the induction of leukemia inhibory factor (LIF). J Neurosci. 13:1993;2601-2609.
65. Terai K., Matsuo A., McGeer E.G., McGeer P.L. Enhancement of immunoreactivity for NF-kappa B in human cerebral infarctions. Brain Res. 739:1996;343-349.
66. Thornberry N.A., Bull H.G., Calaycay J.R., Chapman K.T., Howard A.D., Kostura M.J., Miller D.K., Molineaux S.M., Weidner J.R., Aunins J., et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature. 356:1992;768-774.
67. Toulmond S., Parnet P., Linthorst A.C. When cytokines get on your nerves: cytokine networks and CNS pathologies. Trends Neurosci. 19:1996;409-410.
68. Vanderah T., Laughlin T., Lashbrook J., Nichols M., Wilcox G., Ossipov M., Malan T., Porreca F. Single intrathecal injections of dynorphin A or desTyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxne. Pain. 68:1996;275-281.
69. Wagner R., Janjigian M., Myers R.R. Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression. Pain. 74:1998;35-42.
70. Wang C.X., Olschowka J.A., Wrathall J.R. Increase of interleukin-1beta mRNA and protein in the spinal cord following experimental traumatic injury in the rat. Brain Res. 759:1997;190-196.
71. Wang P., Wu P., Siegel M.I., Egan R.W., Billah M.M. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem. 270:1995;9558-9563.
72. Watkins L.R., Wiertelak B.P., Goehier L.B., Smith K.P., Martin D., Maier S.F. Characterization of cytokine-induced hyperalgesia. Brain Res. 654:1994;15-26.
73. Watkins L.R., Martin D., Ulrich P., Tracey K.J., Maier S.F. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain. 71:1997;225-235.
74. Williams M.B., Jope R.S. Protein synthesis inhibitors attenuate seizures induced in rats by lithium plus pilocarpine. Exp Neurol. 129:1994;169-173.
75. Wong M.L., Rettori V., al-Shekhlee A., Bongiomo P.B., Canteros G., McCann S.M., Gold P.W., Licinio J. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat Med. 2:1996;581-584.
76. Wood J.N. Regulation of NF-kappa B activity in rat dorsal root ganglia and PC12 cells by tumour necrosis factor and nerve growth factor. Neurosci Lett. 192:1995;41-44.
77. Woolf C.J., Allchorne A., Safieh-Garabedian B., Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol. 121:1997;417-424.
78. Yabuuchi K., Maruta B., Minami M., Satoh M. Induction of interleukin-1 beta mRNA in the hypothalamus following subcutaneous injections of formalin into the rat hind paws. Neurosci Lett. 207:1996;109-112.
79. Yabuuchi K., Nishiyori A., Minami M., Satoh M. Biphasic effects of intracerebroventricular interleukin-1 beta on mechanical nociception in the rat. Eur J Pharmacol. 300:1996;59-65.
80. Yakovlev A.G., Faden A.I. Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury. Mol Chem Neuropathol. 23:1994;179-190.
81. Yan H.Q., Banos M.A., Herregodts P., Hooghe R., Hooghe-Peters B.L. Expression of interlinjury. Eur J Immunol. 22:1992;2963-2971.